Free Trial

MediPharm Labs (MEDIF) Short Interest Ratio & Short Volume

MediPharm Labs logo
$0.07 +0.00 (+3.00%)
As of 03:39 PM Eastern

MediPharm Labs Short Interest Data

MediPharm Labs (MEDIF) has a short interest of 205,100 shares. This marks a -30.07% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 116,097 shares to cover all short positions.

Current Short Interest
205,100 shares
Previous Short Interest
293,300 shares
Change Vs. Previous Month
-30.07%
Dollar Volume Sold Short
$11,813.76
Short Interest Ratio
1.2 Days to Cover
Last Record Date
March 15, 2025
Today's Trading Volume
339,544 shares
Average Trading Volume
116,097 shares
Today's Volume Vs. Average
292%
Short Selling MediPharm Labs?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for MediPharm Labs and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MEDIF Short Interest Over Time

MEDIF Days to Cover Over Time

MEDIF Percentage of Float Shorted Over Time

Remove Ads

MediPharm Labs Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025205,100 shares $11,813.76 -30.1%N/A1.2 $0.06
2/28/2025293,300 shares $14,078.40 -31.3%N/A2.1 $0.05
2/15/2025426,700 shares $21,249.66 -1.8%N/A2.3 $0.05
1/31/2025434,400 shares $19,852.08 -14.1%N/A2.6 $0.05
1/15/2025505,500 shares $25,527.75 -15.3%N/A2.8 $0.05
12/31/2024597,100 shares $24,660.23 -15.9%N/A1.4 $0.04
12/15/2024710,100 shares $31,954.50 -2.5%N/A2.6 $0.05
11/30/2024728,000 shares $34,944.00 -5.1%N/A4.5 $0.05
11/15/2024766,900 shares $39,188.59 -10.8%N/A1.9 $0.05
10/31/2024860,100 shares $44,725.20 -3.4%N/A3 $0.05
10/15/2024890,300 shares $46,829.78 -6.4%N/A6.7 $0.05
9/30/2024950,700 shares $47,535.00 No ChangeN/A7.9 $0.05
9/15/2024950,700 shares $44,968.11 No ChangeN/A12.4 $0.05
8/31/2024950,700 shares $44,682.90 -0.4%N/A10.2 $0.05
8/15/2024954,800 shares $49,649.60 -1.8%N/A10.2 $0.05
7/31/2024971,800 shares $51,602.58 -5.1%N/A7.4 $0.05
7/15/20241,023,600 shares $53,124.84 -10.4%N/A9.3 $0.05
6/30/20241,142,000 shares $62,918.49 -0.5%N/A8.7 $0.06
6/15/20241,147,200 shares $61,489.92 +0.4%N/A15.8 $0.05
5/31/20241,142,200 shares $65,790.72 +1.6%N/A6.8 $0.06
5/15/20241,124,100 shares $71,043.12 -2.6%N/A4.3 $0.06
4/30/20241,153,800 shares $79,035.30 -1.5%N/A4.6 $0.07
4/15/20241,171,900 shares $67,032.68 -1.8%N/A12.6 $0.06
3/31/20241,192,800 shares $75,384.96 +2.0%N/A3.4 $0.06
3/15/20241,169,500 shares $56,486.85 -4.0%N/A6.5 $0.05
2/29/20241,218,200 shares $60,057.26 -1.8%N/A5 $0.05
2/15/20241,240,000 shares $63,984.00 -1.8%N/A7 $0.05
1/15/20241,237,300 shares $66,443.01 -0.9%N/A5.1 $0.05
12/31/20231,249,100 shares $60,706.26 +0.1%N/A5.3 $0.05
12/15/20231,248,500 shares $59,928.00 -15.4%N/A6.1 $0.05
11/30/20231,475,900 shares $70,990.79 +14.5%N/A7.3 $0.05
11/15/20231,288,700 shares $64,821.61 -3.6%N/A4.7 $0.05
10/31/20231,337,200 shares $70,203.00 -2.6%N/A7.3 $0.05
10/15/20231,373,400 shares $71,416.80 -0.3%N/A10.3 $0.05
9/30/20231,377,200 shares $73,267.04 -1.2%N/A4.8 $0.05
9/15/20231,393,800 shares $85,718.70 -6.1%N/A4 $0.06
8/31/20231,484,200 shares $94,840.38 +8.5%N/A5.6 $0.06
8/15/20231,367,500 shares $81,092.75 +3.6%N/A3.8 $0.06
7/31/20231,319,900 shares $58,207.59 -2.3%N/A8.5 $0.04
7/15/20231,351,000 shares $63,497.00 +3.8%N/A8 $0.05
Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
6/30/20231,302,000 shares $59,501.40 -1.7%N/A4.3 $0.05
6/15/20231,324,900 shares $66,245.00 -1.7%N/A4.6 $0.05
5/31/20231,348,100 shares $68,483.48 +2.0%N/A9.7 $0.05
5/15/20231,322,000 shares $75,354.00 -2.0%N/A19 $0.06
4/30/20231,349,200 shares $74,206.00 -16.8%N/A3.7 $0.06
4/15/20231,621,500 shares $113,505.00 +20.4%N/A2.5 $0.07
3/31/20231,346,600 shares $68,676.60 -4.2%N/A21.9 $0.05
3/15/20231,405,300 shares $74,480.90 +3.7%N/A5.6 $0.05
2/28/20231,355,300 shares $78,607.40 -3.2%N/A8.2 $0.06
2/15/20231,399,400 shares $87,462.50 +1.3%N/A12.9 $0.06
1/31/20231,381,700 shares $84,283.70 -2.5%N/A6.2 $0.06
1/15/20231,417,100 shares $76,523.40 +1.7%N/A13.3 $0.05
12/30/20221,393,500 shares $67,863.45 -3.1%N/A6.2 $0.05
12/15/20221,438,500 shares $77,679.00 -2.5%N/A11.3 $0.05
11/30/20221,475,000 shares $93,662.50 -14.5%N/A5.5 $0.06
11/15/20221,725,000 shares $109,020.00 -5.1%N/A3.9 $0.06
10/31/20221,816,900 shares $106,833.72 -0.1%N/A13.7 $0.06
10/15/20221,818,200 shares $97,364.61 -6.8%N/A9.5 $0.05
9/30/20221,951,600 shares $104,410.60 -9.8%N/A11 $0.05
9/15/20222,162,500 shares $122,276.40 -0.3%N/A23.8 $0.06
8/31/20222,168,700 shares $117,109.80 +7.7%N/A9.4 $0.05
8/15/20222,014,400 shares $136,576.32 -4.6%N/A9.9 $0.07
7/31/20222,111,200 shares $136,383.52 -12.3%N/A10.7 $0.06
7/15/20222,406,800 shares $126,838.36 +2.7%N/A11 $0.05
6/30/20222,344,500 shares $131,057.55 -4.1%N/A8.6 $0.06
6/15/20222,443,800 shares $131,965.20 -9.1%N/A8.9 $0.05
5/31/20222,689,500 shares $166,749.00 -10.6%N/A6.7 $0.06
5/15/20223,007,700 shares $202,117.44 +1.8%N/A6.8 $0.07
4/30/20222,953,500 shares $282,206.93 -6.3%N/A9.5 $0.10
4/15/20223,152,400 shares $337,227.99 +2.2%N/A11.3 $0.11
3/31/20223,084,500 shares $459,590.50 -10.8%N/A9 $0.15
3/15/20223,458,400 shares $390,453.36 +1.7%N/A8.3 $0.11
2/28/20223,400,000 shares $433,840.00 -5.2%N/A6.4 $0.13
2/15/20223,585,800 shares $485,158.74 -26.4%N/A9.2 $0.14
1/31/20224,871,000 shares $780,821.30 -0.4%N/A14.1 $0.16
1/15/20224,891,200 shares $842,753.76 -31.6%N/A23.3 $0.17
12/31/20217,150,600 shares $1.05 million +13.9%N/A8.5 $0.15
12/15/20216,278,900 shares $879,046.00 +20.8%N/A10.7 $0.14
11/30/20215,197,300 shares $847,159.90 +4.9%N/A9.6 $0.16
11/15/20214,955,000 shares $1.09 million -4.1%N/A17.2 $0.22
10/29/20215,164,700 shares $1.07 million +5.2%N/A21.6 $0.21
10/15/20214,911,000 shares $1.07 million -6.2%N/A15.6 $0.22
9/30/20215,234,700 shares $1.05 million -55.6%N/A13.1 $0.20
9/15/202111,776,100 shares $3.04 million -3.1%N/A41.6 $0.26
8/31/202112,146,300 shares $3.27 million -0.6%N/A32.2 $0.27
8/13/202112,225,000 shares $3.83 million -1.8%N/A48.3 $0.31
7/30/202112,444,200 shares $4.32 million -1.7%N/A52.4 $0.35
7/15/202112,652,700 shares $4.49 million -0.3%N/A50.3 $0.36
6/30/202112,690,000 shares $4.71 million +4.4%N/A38.4 $0.37
6/15/202112,160,800 shares $4.80 million +11.6%N/A21.6 $0.39
Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
5/28/202110,898,900 shares $5.01 million +19.5%N/A18.9 $0.46
5/14/20219,118,700 shares $2.96 million +8.4%N/A12 $0.32
4/30/20218,411,900 shares $3.27 million +6.2%N/A18.5 $0.39
4/15/20217,921,300 shares $2.98 million -11.6%N/A9.3 $0.38
3/31/20218,958,500 shares $3.23 million +32.7%N/A9.6 $0.36
3/15/20216,750,300 shares $2.65 million +35.4%N/A2.8 $0.39
2/26/20214,986,000 shares $2.89 million -57.7%N/A2.5 $0.58
2/12/202111,790,200 shares $8.39 million -0.5%N/A4.4 $0.71
1/29/202111,845,300 shares $5.93 million -1.8%N/A10.7 $0.50
1/15/202110,330,600 shares $6.82 million +27.0%N/A19.3 $0.66
12/31/202011,346,600 shares $4.46 million +9.8%N/A17.8 $0.39
12/15/202010,330,600 shares $4.44 million +27.0%N/A19.3 $0.43
11/30/20208,134,000 shares $3.42 million +40.1%N/A10.3 $0.42
11/15/20205,806,800 shares $3.36 million +26.3%N/A12.4 $0.58
10/30/20204,598,000 shares $2.89 million +5.7%N/A14.8 $0.63
10/15/20204,349,400 shares $3.17 million +2.6%N/A13 $0.73
9/30/20204,237,500 shares $2.78 million +19.1%N/A14.9 $0.66
9/15/20203,558,300 shares $2.60 million -9.0%N/A9.5 $0.73
8/31/20203,910,500 shares $2.82 million -30.6%N/A11 $0.72
8/14/20205,637,100 shares $4.13 million -1.9%N/A21.8 $0.73
7/31/20205,745,100 shares $4.57 million +0.9%N/A16.5 $0.80
7/15/20205,694,800 shares $4.95 million +4.4%N/A16.7 $0.87
6/30/20205,457,500 shares $4.90 million +30.6%N/A6 $0.90
6/15/20204,178,600 shares $5.56 million -2.6%N/A6.4 $1.33
5/29/20204,291,100 shares $5.99 million +11.8%N/A7.3 $1.40
5/15/20203,839,900 shares $4.80 million -0.6%N/A10.9 $1.25
4/30/20203,731,800 shares $5.26 million +8.4%N/A11.1 $1.41
4/15/20203,443,600 shares $4.06 million -7.9%N/A7.8 $1.18

MEDIF Short Interest - Frequently Asked Questions

What is MediPharm Labs' current short interest?

Short interest is the volume of MediPharm Labs shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 205,100 shares of MEDIF short. Learn More on MediPharm Labs' current short interest.

What is a good short interest ratio for MediPharm Labs?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEDIF shares currently have a short interest ratio of 1.0. Learn More on MediPharm Labs's short interest ratio.

Is MediPharm Labs' short interest increasing or decreasing?

MediPharm Labs saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 205,100 shares, a decrease of 30.1% from the previous total of 293,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short MediPharm Labs stock?

Short selling MEDIF is an investing strategy that aims to generate trading profit from MediPharm Labs as its price is falling. MEDIF shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against MediPharm Labs?

A short squeeze for MediPharm Labs occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDIF, which in turn drives the price of the stock up even further.

How often is MediPharm Labs' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDIF, twice per month. The most recent reporting period available is March, 15 2025.




This page (OTCMKTS:MEDIF) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners